Four IRIC researchers receive Canadian Institutes of Health Research grants
Published on February 4, 2022
The Canadian Institutes of Health Research (CIHR) recently awarded Project Grants for the Fall 2021 competition.
The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health.
In the Fall 2021 competition, four IRIC research teams were awarded prestigious grants.
Congratulations to our community:
- Geneviève Deblois, director of the Metabolic and Epigenetic Alterations in Cancer Research Unit, receives a grant of $619,650 over five years, for the project entitled “Investigating the metabolic determinants of triple-negative breast cancer progression through chromatin dependencies.”
- Sylvain Meloche, director of the Signalling and Cell Growth Research Unit, receives a one-year grant of $100,000 for the project “Development and preclinical validation of first-in-class dual inhibitors of the atypical MAP kinases ERK3 and ERK4.”
- Philippe P. Roux, director of the Cell Signalling and Proteomics Research Unit, receives a grant of $921,825 over five years for the project “Targeting ENPP1-dependent immune evasion in ErbB2-positive breast cancer.
- Guy Sauvageau, director of the Molecular Genetics of Stem Cells Research Unit, receives a grant of $908,438 over five years for the project “Understanding the GR/PLZF axis in acute myeloid leukemia.”